Navigation Links
Rotech Receives Approval of First Day Motions; Approvals Ensure Operations Continue Normally
Date:4/10/2013

ctors that could cause actual results to differ materially from those contained in the forward-looking statements. Such forward-looking statements include, but are not limited to that the Company will have sufficient cash on hand to pay its operating expenses; the Company's ability to continue to comply with other covenants under its notes or credit facility; potential decreases in Medicare Part B reimbursement rates; legislative or regulatory changes to Medicare or related programs; health care reform, including recently enacted legislation; adjustments in reimbursement rates set by the Centers for Medicare & Medicaid Services; the effects of the competitive bidding process under Medicare; the accreditation of the Company's operating locations and their compliance with government standards for coverage and payment; the ability of the Company to develop, secure approval of and consummate a prearranged plan of chapter 11 reorganization; the Company's ability to improve its operating structure, financial results and profitability following emergence from chapter 11; the potential adverse effects of the chapter 11 proceedings on the Company's liquidity, results of operations, brand or business prospects; the Company's ability to generate or raise cash and maintain a cash balance sufficient to fund continued investments, capital needs and service its debt; the Company's ability to maintain contracts that are critical to its operation; the Company's ability to obtain and maintain normal terms with customers, suppliers and service providers; and the Company's ability to retain key executives, managers and employees.  Additional factors that may affect future results are contained in the Company's filings with the Securities and Exchange Commission (the "SEC"), which are available at the SEC's website at www.sec.gov.  The Company disclaims any obligation to update and revise statements contained in these materials based on new
'/>"/>
SOURCE Rotech Healthcare Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Market for Neurotechnology 2012-2018
2. Neurotech Reports Announces New Conference Dedicated to Consumer Applications of Neurotechnology
3. Neuralstem Receives Notice Of Allowance Of Patent Covering Use Of Stem Cells To Treat Amyotrophic Lateral Sclerosis
4. CryoLife Receives FDA Clearance For Next Generation HeRO Device
5. Hurel Receives $9.2 Million Series A Funding From Spring Mountain Capital
6. Kaiser Permanente Receives Award for Excellence in Medication Safety
7. Tengion Receives MPA Approval of CTA for Neo-Kidney Augment Phase 1 Trial in Sweden
8. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
9. Quantel Medical Receives FDA Clearance for new Vitra Multispot Laser System
10. NW Bio Receives U.S. Patent On Broad Processes For Producing More Potent Dendritic Cells
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 The National Space Biomedical ... Center for Space Radiation Research (CSRR) under the leadership ... an Associate Professor of Pharmaceutical Sciences within the University ... Division of Radiation Health. She is located in ... a team of investigators working across four U.S. institutions, ...
(Date:7/22/2014)... , July 22, 2014  Decision Resources Group finds that ... Canada will remain relatively stagnant at a value ... fact that percutaneous coronary intervention (PCI) volumes are growing faster ... markets, such as the United States ... largely driven by the increase in penetration of PCI procedures ...
(Date:7/22/2014)... July 22, 2014  Decision Resources Group finds ... (MS) patients currently treated with Biogen Idec,s ... experienced flushing and/or gastrointestinal events while on ... currently experiencing these side effects, signifying either ... management of such events. In the end, ...
Breaking Medicine Technology:Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3
... 14 New England Biolabs (NEB) has launched ... to simplify DNA methylation analysis for epigenetics researchers. ... of the current methods, including the lack of ... of 5-hydroxymethlcytosine (5-hmC) in the epigenome. ...
... Fe and Femcon® Fe... -- ARDEE, Ireland, Oct. 14 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Medicine Technology:New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome 2Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 2Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 3Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 4Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 5Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 6Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 7Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 8Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 9Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations 10
(Date:7/22/2014)... Aaron Marshall, Corporate Counsel at Northrop Grumman, will serve ... for the 2014-2015 fiscal year. He joined the Board ... "“Serving on the HASA board has given me a broader, ... remember how much others need help." , ABOUT AARON MARSHALL:, ... a B.S. in Finance from the University of Delaware. Currently, ...
(Date:7/22/2014)... The American Society of Hematology (ASH) will honor ... Los Angeles with the 2014 E. Donnall Thomas ... the discovery of the iron-regulatory hormone hepcidin and investigation ... after the Nobel Prize Laureate and past Society president ... hematology that have represented a paradigm shift or significant ...
(Date:7/22/2014)... Robert E. Marc, Ph.D., director of research at the ... been named by the International Society of Eye Research ... Research Foundation,s 2014 Paul Kayser International Award in Retina ... scientist who has made a significant contribution to the ... being presented this week at the ISER Biennial Meeting ...
(Date:7/22/2014)... As reported on July 17, 2014 by ABC ... her favorite beauty products, “ Botox , that’s pretty much ... Botox has changed my life” by halving the amount ... her various, daily appearances. “Suddenly my eyelids are no ... , “I think that Kelly Ripa’s response to the question ...
(Date:7/22/2014)... Latin American Conference on Lung Cancer (LALCA 2014) will ... Peru. , Lung Cancer is still the leading cause ... Building on the success of the previous conferences in ... will discuss the science and advances in the treatment ... and Latin America in particular. , With tobacco being ...
Breaking Medicine News(10 mins):Health News:New Board President for Baltimore-based Nonprofit 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 2Health News:Tomas Ganz, M.D., Ph.D., to present 2014 ASH E. Donnall Thomas Lecture 3Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:Celebrity Botox: Kelly Ripa Confesses to Getting Botox Injections 2
... human body, HOUSTON, Sept. 25 Can you ... Simply visit The John P. McGovern Museum of Health ... explore the latest,exhibit -- Sesame Street Presents: The Body ... October 4, 2007 and January 13, 2008.,The exhibit offers ...
... 25 A Place for Mom, the nation,s largest,referral ... that John,Temple, Chief Operating Officer was named to the ... The 40 Under 40 List is the Pacific Northwest ... They look for,nominees that work hard to drive the ...
... Phase II data presented today suggest that ZD4054, a ... with Hormone Resistant Prostate Cancer (HRPC), could offer a ... HRPC who were asymptomatic or mildly symptomatic for pain.1 ... percent reduction in the risk of death compared to ...
... 25 ThermoSpas, the country,s,largest hot tub retailer, ... chronically,ill children to give specially-designed therapeutic hot tubs ... program, the company will donate 12,ThermoSpas hot tubs ... who will benefit,from warm water therapy. ThermoSpas encourages ...
... Continuum Health Partners Selects Ericom(R) PowerTerm(R) WebConnect for ... ... 25 Continuum Health Partners, a,New York-based non-profit hospital system, ... of Continuum,s strategy to,provide doctors and staff with secure, on-demand ...
... youngsters to stay healthy, , , TUEDAY, Sept. 25 (HealthDay News) ... and way too much junk food are pushing U.S. children ... new studies finds. , The studies -- published in a ... -- show the myriad challenges youngsters face every day ...
Cached Medicine News:Health News:Sesame Street Exhibition Makes Texas Premier at The Health Museum 2Health News:Sesame Street Exhibition Makes Texas Premier at The Health Museum 3Health News:Sesame Street Exhibition Makes Texas Premier at The Health Museum 4Health News:Sesame Street Exhibition Makes Texas Premier at The Health Museum 5Health News:Sesame Street Exhibition Makes Texas Premier at The Health Museum 6Health News:A Place for Mom COO Makes Seattle's 40 Under 40 List 2Health News:Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054 2Health News:Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054 3Health News:Photos: America's Chronically Ill Children Have New Hope with 'Hot' Gift 2Health News:Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization 2Health News:Junk Food, TV Driving Kids to Obesity 2Health News:Junk Food, TV Driving Kids to Obesity 3Health News:Junk Food, TV Driving Kids to Obesity 4
... Laboratories offers a comprehensive line of pregnancy ... and urine in convenient one-step stick and ... testing options. Clearview Easy HCG is a ... stick format. Clearview HCG II provides ...
... is based on sequential binding of HCG ... (specific for the *-chain of HCG) immobilized ... for the *-chain of HCG) conjugated to ... step, chromogenic substrate is added and colors ...
... Laboratories offers a comprehensive line of pregnancy ... and urine in convenient one-step stick and ... testing options. Clearview Easy HCG is a ... stick format. Clearview HCG II provides ...
For the quantitative determination of Glycohemoglobin in blood....
Medicine Products: